InvestorsObserver
×
News Home

Where Will Caribou Biosciences Inc (CRBU) Stock Go Next After It Is Down 31.04% in a Week?

Wednesday, March 13, 2024 10:51 AM | InvestorsObserver Analysts

Mentioned in this article

Where Will Caribou Biosciences Inc (CRBU) Stock Go Next After It Is Down 31.04% in a Week?

The market has been down on Caribou Biosciences Inc (CRBU) stock recently. CRBU gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Caribou Biosciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CRBU!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CRBU Stock Today?

Caribou Biosciences Inc (CRBU) stock has risen 1.69% while the S&P 500 is down -0.09% as of 10:50 AM on Wednesday, Mar 13. CRBU is up $0.09 from the previous closing price of $5.02 on volume of 1,147,849 shares. Over the past year the S&P 500 has risen 34.10% while CRBU is down -4.13%. CRBU lost -$1.38 per share in the over the last 12 months.

More About Caribou Biosciences Inc

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Click Here to get the full Stock Report for Caribou Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App